Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Huaren Pharmaceutical (300110)
- 3.09
- +0.04+1.31%
Market Closed Apr 24 15:00 CST
3.65BMarket Cap-7.88P/E (TTM)
3.10High3.03Low250.50KlotVolume3.05Open3.05Prev Close76.93MTurnover2.12%Turnover RatioLossP/E (Static)1.18BShares3.7552wk High4.28P/B3.65BFloat Cap2.8252wk Low3.66Limit Up1.18BShs Float15.21Historical High2.44Limit Down2.30%Range %2.05Historical Low--Dividend TTM3.07Avg Price120.80KlotAsk--Div Yield TTM100Lot Size125.80KlotBid
Huaren Pharmaceutical (300110) Income Statement
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 2.14%309.97M | -2.34%1.32B | -9.07%976.27M | -19.13%623.9M | -25.38%303.47M | -17.30%1.35B | -11.70%1.07B | -6.95%771.46M | 0.86%406.7M | 1.04%1.64B |
| Operating revenue | 2.14%309.97M | -2.34%1.32B | -9.07%976.27M | -19.13%623.9M | -25.38%303.47M | -17.30%1.35B | -11.70%1.07B | -6.95%771.46M | 0.86%406.7M | 1.04%1.64B |
| Other operating revenue | ---- | 4.98%16.17M | ---- | -82.33%5.08M | ---- | -83.97%15.41M | ---- | 2.01%28.72M | ---- | 123.29%96.11M |
| Total operating cost | 2.99%289.56M | -5.18%1.2B | -5.76%908.11M | -15.15%580.3M | -17.53%281.16M | -9.58%1.27B | -6.65%963.61M | -5.14%683.87M | -2.52%340.91M | 0.55%1.4B |
| Operating cost | 7.03%206.9M | -5.12%831.92M | -6.29%642.9M | -19.10%388.48M | -17.99%193.32M | -6.44%876.83M | 0.46%686.06M | 0.16%480.2M | 0.21%235.73M | 2.01%937.2M |
| Operating tax surcharges | -4.70%5.53M | -5.84%21.66M | -5.01%15.89M | -9.72%10.59M | -6.94%5.81M | -6.33%23.01M | -7.76%16.73M | -6.66%11.73M | -9.88%6.24M | -8.20%24.56M |
| Operating expense | -2.47%30.63M | 6.10%150.36M | 4.13%101.31M | 5.14%83.11M | -26.75%31.41M | -33.77%141.72M | -40.34%97.29M | -32.02%79.05M | -22.10%42.88M | -5.08%213.99M |
| Administration expense | 0.97%22.79M | -10.97%90.39M | -6.79%65.86M | -5.86%44.68M | 3.05%22.57M | 4.62%101.53M | -4.40%70.66M | -4.81%47.46M | -4.28%21.9M | -7.99%97.04M |
| Financial expense | -29.23%9.62M | -22.88%42.3M | -21.95%33.78M | -23.19%23.47M | -15.08%13.6M | -13.40%54.85M | -14.85%43.28M | -10.78%30.56M | 8.30%16.01M | -3.25%63.34M |
| -Interest expense (Financial expense) | -16.51%9.36M | -22.73%41.97M | -22.36%31.59M | -22.90%21.24M | -26.54%11.21M | -11.70%54.32M | -14.13%40.69M | -14.52%27.54M | 3.30%15.26M | -4.12%61.51M |
| -Interest Income (Financial expense) | 61.49%-53.03K | 43.70%-523.3K | 45.34%-287.1K | 42.96%-239.41K | 44.80%-137.7K | 56.94%-929.47K | 29.49%-525.29K | 25.45%-419.7K | -1.88%-249.44K | 54.75%-2.16M |
| Research and development | -2.65%14.08M | -6.18%67.83M | -2.44%48.37M | -14.08%29.96M | -20.36%14.46M | 5.26%72.29M | 14.17%49.58M | 22.11%34.87M | 22.21%18.16M | 24.19%68.68M |
| Credit Impairment Loss | 107.81%546.57K | 98.31%-22.9M | -1,429.41%-13.97M | -87.58%-10.47M | 20.85%-7M | -10,788.52%-1.35B | 97.57%-913.34K | 77.75%-5.58M | -13.39%-8.84M | 72.26%-12.43M |
| Asset Impairment Loss | 100.89%9.56K | -485.37%-563.22M | 23.36%-1.11M | 23.36%-1.11M | 25.73%-1.08M | -916.18%-96.22M | -496.95%-1.45M | -170.84%-1.45M | ---1.45M | 18.30%-9.47M |
| Adjustment items of total operating cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- |
| Other net revenue | 149.58%2.5M | 60.12%-572.69M | -179.80%-5.48M | -331.41%-1.76M | 29.05%-5.05M | -26,024.23%-1.44B | 123.76%6.86M | 103.87%760.9K | -3.92%-7.11M | 76.96%-5.5M |
| Invest income | -81.77%-44.28K | 512.30%4.82M | 539.60%2.28M | 544.18%2.3M | ---24.36K | -238.43%-1.17M | 18.30%356.76K | 18.30%356.76K | ---- | 160.87%843.78K |
| Asset deal income | --0 | -55.48%7.33K | --0 | --0 | --0 | -99.62%16.47K | -99.88%5.67K | -99.88%5.67K | ---- | -68.61%4.35M |
| Other revenue | -34.90%1.99M | -40.00%8.61M | -17.42%7.32M | 1.23%7.52M | -4.00%3.06M | 28.17%14.36M | 155.60%8.87M | 595.48%7.43M | 233.09%3.18M | -44.12%11.2M |
| Operating profit | 32.69%22.91M | 66.32%-455.7M | -46.37%62.68M | -52.65%41.84M | -70.58%17.26M | -698.82%-1.35B | -24.47%116.88M | -0.10%88.35M | 25.71%58.68M | 13.83%225.94M |
| Add:Non operating Income | -97.79%46.75K | 1,914.16%2.57M | 274.47%2.18M | 789.38%2.15M | 12,213.08%2.12M | -98.15%127.5K | -81.61%582.19K | -91.31%241.73K | -87.38%17.2K | -45.54%6.89M |
| Less:Non operating expense | 155.72%2.87M | 101.18%5.81M | -48.04%1.59M | -21.89%1.14M | 12.56%1.12M | 24.34%2.89M | 335.80%3.05M | 191.58%1.46M | 1,457.20%998.48K | -56.07%2.32M |
| Total profit | 9.98%20.08M | 66.15%-458.94M | -44.69%63.28M | -50.82%42.85M | -68.36%18.26M | -688.14%-1.36B | -27.23%114.41M | -3.95%87.13M | 23.42%57.7M | 11.98%230.51M |
| Less:Income tax cost | 91.50%3.28M | -93.67%447.76K | -57.82%5.88M | -64.65%3.68M | -67.85%1.71M | -80.92%7.08M | -15.84%13.94M | 65.90%10.42M | 9.01%5.32M | 51.03%37.09M |
| Net profit | 1.55%16.8M | 66.29%-459.39M | -42.87%57.4M | -48.95%39.16M | -68.41%16.55M | -804.58%-1.36B | -28.57%100.47M | -9.15%76.71M | 25.10%52.38M | 6.69%193.42M |
| Net profit from continuing operation | 1.55%16.8M | 66.29%-459.39M | -42.87%57.4M | -48.95%39.16M | -68.41%16.55M | -804.58%-1.36B | -28.57%100.47M | -9.15%76.71M | 25.10%52.38M | 6.69%193.42M |
| Less:Minority Profit | 63.03%844.81K | -37.82%3.51M | -42.95%2.82M | -47.68%1.83M | -66.68%518.18K | 5.32%5.65M | 38.48%4.94M | 62.39%3.5M | 102.57%1.56M | 927.55%5.36M |
| Net profit of parent company owners | -0.44%15.96M | 66.17%-462.9M | -42.87%54.58M | -49.01%37.33M | -68.46%16.03M | -827.67%-1.37B | -30.31%95.53M | -11.02%73.21M | 23.65%50.82M | 4.03%188.06M |
| Earning per share | ||||||||||
| Basic earning per share | -0.74%0.0135 | 66.17%-0.3916 | -42.82%0.0462 | -48.95%0.0316 | -68.37%0.0136 | -827.59%-1.1576 | -30.34%0.0808 | -11.06%0.0619 | 23.56%0.043 | 3.99%0.1591 |
| Diluted earning per share | -0.74%0.0135 | 66.17%-0.3916 | -42.82%0.0462 | -48.95%0.0316 | -68.37%0.0136 | -827.59%-1.1576 | -30.34%0.0808 | -11.06%0.0619 | 23.56%0.043 | 3.99%0.1591 |
| Other composite income | ||||||||||
| Total composite income | 1.55%16.8M | 66.29%-459.39M | -42.87%57.4M | -48.95%39.16M | -68.41%16.55M | -804.58%-1.36B | -28.57%100.47M | -9.15%76.71M | 25.10%52.38M | 6.69%193.42M |
| Total composite income of parent company owners | -0.44%15.96M | 66.17%-462.9M | -42.87%54.58M | -49.01%37.33M | -68.46%16.03M | -827.67%-1.37B | -30.31%95.53M | -11.02%73.21M | 23.65%50.82M | 4.03%188.06M |
| Total composite income of minority owners | 63.03%844.81K | -37.82%3.51M | -42.95%2.82M | -47.68%1.83M | -66.68%518.18K | 5.32%5.65M | 38.48%4.94M | 62.39%3.5M | 102.57%1.56M | 927.55%5.36M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Zhongxinghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongxinghua Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhongxinghua Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm